Homeopathic and Anthroposophic Medicinal Products in the EU – The added value of the sector

A new report from ECHAMP provides an updated comprehensive summary of the scientific evidence that demonstrates the significant added value to society of homeopathy and anthroposophic medicine.

A new report from ECHAMP provides an updated comprehensive summary of the scientific evidence that demonstrates the significant added value to society of homeopathy and anthroposophic medicine.

The report, ‘Homeopathic and Anthroposophic Medicinal Products in the EU – The added value of the sector,’ presents an overview of the current evidence base for these therapeutic systems and their related products and outlines the role that they can play in the face of today’s health challenges in the EU.

It includes sections on: clinical and comparative effectiveness; the safety profile of the medicinal products; the cost-effectiveness of these systems of medicine; and additional study references demonstrating the potential contribution of these medicines in fields of specific relevance to EU health policy priorities including children and young people, polypharmacy, non-communicable diseases and healthy ageing. It summarises current evidence that suggests that they can contribute to safe and effective strategies to reduce the use of antibiotics, in line with EU health goals.

The report shows how, taken together, these studies form a substantial body of scientific research that demonstrates the effectiveness of these forms of treatment, supported by a growing body of published clinical studies that confirm their real-world effectiveness. ECHAMP hopes the report will serve to encourage further research to evaluate the benefit of homeopathy and anthroposophic medicine for different health conditions and as a tool for policy makers, with a view to ensuring inclusive and integrated healthcare that reflects the needs of the millions of European patients that choose to use these products.

Further information

• Homeopathic and Anthroposophic Medicinal Products in the EU – The added value of the sector, ECHAMP